Perillaldehyde has been shown to reduce bone metastasis of PC-3 prostate cancer cells with repression of the nuclear factor-κB (NF-κB) pathway and receptor activator of NF-κB ligand (RANKL) [52]. The gene discussed is NFKB1; the disease is Familial prostate cancer.